Ardea Biosciences, Inc./DE 4
Accession 0001209191-12-034779
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:52 PM ET
Size
45.0 KB
Accession
0001209191-12-034779
Insider Transaction Report
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$16.31/sh−12,500$203,875→ 0 totalExercise: $15.69Exp: 2018-01-01→ Common Stock (12,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$19.84/sh−12,500$248,000→ 0 totalExercise: $12.16Exp: 2019-01-01→ Common Stock (12,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$6.03/sh−12,500$75,375→ 0 totalExercise: $25.97Exp: 2021-01-02→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−3,733,582$119,474,624→ 0 total(indirect: By LP) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$26.15/sh−2,500$65,375→ 0 totalExercise: $5.85Exp: 2017-06-14→ Common Stock (2,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$19.84/sh−5,000$99,200→ 0 totalExercise: $12.16Exp: 2019-01-01→ Common Stock (5,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$17.71/sh−12,500$221,375→ 0 totalExercise: $14.29Exp: 2020-01-03→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock Warrant (right to buy)
2012-06-19$20.86/sh−39,163$816,940→ 0 total(indirect: By LP)Exercise: $11.14Exp: 2013-12-18→ Common Stock (39,163 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$18.07/sh−25,000$451,750→ 0 totalExercise: $13.93Exp: 2014-06-10→ Common Stock (25,000 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−67,052$2,145,664→ 0 total(indirect: By Trust) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$15.51/sh−5,000$77,550→ 0 totalExercise: $16.49Exp: 2014-02-01→ Common Stock (5,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$27.92/sh−10,000$279,200→ 0 totalExercise: $4.08Exp: 2015-01-02→ Common Stock (10,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$27.76/sh−12,500$347,000→ 0 totalExercise: $4.24Exp: 2017-01-02→ Common Stock (12,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$26.15/sh−1,250$32,688→ 0 totalExercise: $5.85Exp: 2017-06-14→ Common Stock (1,250 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$16.31/sh−7,500$122,325→ 0 totalExercise: $15.69Exp: 2018-01-01→ Common Stock (7,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$19.84/sh−2,500$49,600→ 0 totalExercise: $12.16Exp: 2019-01-01→ Common Stock (2,500 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$15.53/sh−12,500$194,125→ 0 totalExercise: $16.47Exp: 2022-01-02→ Common Stock (12,500 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−15,089$482,848→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$28.50/sh−12,500$356,250→ 0 totalExercise: $3.50Exp: 2016-02-12→ Common Stock (12,500 underlying)
Footnotes (5)
- [F1]The securities are owned by Kevin C. Tang's IRA.
- [F2]The securities are owned by Kevin C. Tang as custodian for his minor children and as Trustee of the Tang Advisors, LLC Profit Sharing Plan, for which Mr. Tang serves as Trustee and in which he is a participant. Mr. Tang disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F3]The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Mr. Tang disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- [F4]This option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 21, 2012, by and among Ardea Biosciences, Inc. ("Ardea"), Zeneca Inc. and QAM Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the option; and (ii) the number of shares of Ardea common stock underlying the option.
- [F5]This warrant was canceled pursuant to the Merger Agreement in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the warrant; and (ii) the number of shares of Ardea common stock underlying the warrant.
Documents
Issuer
Ardea Biosciences, Inc./DE
CIK 0001103390
Related Parties
1- filerCIK 0001103390
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:52 PM ET
- Size
- 45.0 KB